About Alentis Therapeutics
5 Job openings in Egicat
Alentis Therapeutics the Claudin1 Company is on a mission to treat cancer and reverse fibrosis. To this end we are rapidly advancing a clinical pipeline of antiClaudin1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin1 and More...
Alentis Therapeutics the Claudin1 Company is on a mission to treat cancer and reverse fibrosis. To this end we are rapidly advancing a clinical pipeline of antiClaudin1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin1 and More...
Alentis Therapeutics the Claudin1 Company is on a mission to treat cancer and reverse fibrosis. To this end we are rapidly advancing a clinical pipeline of antiClaudin1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin1 and More...
Alentis Therapeutics the Claudin1 Company is on a mission to treat cancer and reverse fibrosis. To this end we are rapidly advancing a clinical pipeline of antiClaudin1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin1 and More...
Alentis Therapeutics is developing breakthrough treatments for fibrotic and rare diseases and associated cancers. The companys lead candidates are monoclonal antibodies that are highly selective for exposed and nonjunctional Claudin1 (CLDN1). Nonjunctional CLDN1 is a previously unexpl More...
